Anupam Rasayan India Limited
NSE: ANURAS | Information Technology
Market Fundamentals
Stock Intelligence & News
Anupam Rasayan India Ltd (543275)
Submission of Scrutinizer''s Report along with e-voting results of 23rd Annual General Meeting held on September 30, 2026.
Read Full Analysis →Anupam Finserv Ltd (530109)
Please find attached Voting Results and Scrutinizer Report for the 35th Annual General Meeting
Read Full Analysis →Bliss GVS Pharma Ltd (506197)
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anupam Rasayan India Ltd
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Anupam Rasayan India Ltd (543275)
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 30, 2026 for Anand Sureshbhai Desai
Read Full Analysis →Anupam Finserv Ltd (530109)
Please find attached Outcome and Proceedings of 35th Annua General Meeting of the Company.
Read Full Analysis →Anupam Rasayan India Ltd (543275)
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Read Full Analysis →Surat-based Anupam Rasayan completes ₹1,750-cr acquisition of 48.2% in Bliss GVS Pharma
This marks Anupam Rasayan’s third strategic inorganic transaction, as the Surat-based specialty chemicals maker expands into finished pharmaceutical formulations
Read Full Analysis →Buzzing stocks: Tata Group, Anupam Rasayan, HCLSoftware, IRFC, NCC, Pidilite and others in focus
Corporate restructuring, strategic acquisitions, new partnerships, major project orders, fleet expansion and renewable-energy capacity additions marked a busy day of announcements from Indian companies
Read Full Analysis →Anupam Rasayan India Limited
Anupam Rasayan India Limited has informed the Exchange about acquisition of equity shares of Bliss GVS Pharma Limited. |SUBJECT: General Updates
Read Full Analysis →Anupam Rasayan India Limited
Anupam Rasayan India Limited has informed the Exchange regarding a press release titled "Anupam Rasayan Concludes Acquisition of Bliss GVS Pharma, Marks Third Strategic Step Towards Building an Integrated Global Pharma Platform". |SUBJECT: Press Release
Read Full Analysis →Get instant alerts when ANURAS breaks news
Join investors who track Anupam Rasayan India Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for ANURAS?
ANURAS is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Anupam Rasayan India Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding ANURAS to your custom watchlist.